# OnCo record nct06598007 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06598007/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06598007", "NCT06598007" ;
  schema:name "A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of FOLFOX, FLOT, CAPOX in colorectal cancer and pancreatic ductal adenocarcinoma, run by Crossignal Therapeutics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06598007/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06598007> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2024-09-20" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/flot/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/ct3001/> .